|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2003-10-8
|
|
pubmed:abstractText |
Systemic adenoviral (Ad) gene therapy for renal disorders is largely hampered by the unique architecture of the kidney. Consequently, currently available Ad vectors are of only limited therapeutic utility in the context of glomerular and fibroproliferative renal diseases.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1099-498X
|
|
pubmed:author |
pubmed-author:CareyDelicia EDE,
pubmed-author:CookWilliamW,
pubmed-author:CurielDavid TDT,
pubmed-author:HavivYosef SYS,
pubmed-author:LamJohn TJT,
pubmed-author:LeiXiaoshengX,
pubmed-author:NagiPeter APA,
pubmed-author:NaitoSeijiS,
pubmed-author:TakayamaKoichiK,
pubmed-author:ToussonAlbertA,
pubmed-author:WangMinghuiM
|
|
pubmed:copyrightInfo |
Copyright 2003 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
839-51
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14533192-Adenoviridae,
pubmed-meshheading:14533192-Animals,
pubmed-meshheading:14533192-Disease Models, Animal,
pubmed-meshheading:14533192-Fibrosis,
pubmed-meshheading:14533192-Gene Therapy,
pubmed-meshheading:14533192-Gene Transfer Techniques,
pubmed-meshheading:14533192-Genetic Vectors,
pubmed-meshheading:14533192-Glomerulonephritis,
pubmed-meshheading:14533192-Injections, Intramuscular,
pubmed-meshheading:14533192-Kidney,
pubmed-meshheading:14533192-Kidney Diseases,
pubmed-meshheading:14533192-Mice,
pubmed-meshheading:14533192-Mice, Inbred BALB C,
pubmed-meshheading:14533192-Protein-Serine-Threonine Kinases,
pubmed-meshheading:14533192-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:14533192-Recombinant Fusion Proteins,
pubmed-meshheading:14533192-Transforming Growth Factor beta
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule.
|
|
pubmed:affiliation |
Division of Human Gene Therapy, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-2172, USA. yosef.haviv@ccc.uab.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
